|
| [December 11, 2012] |
 |
Research and Markets: Global Dermatology Drug Pipeline Capsule - 2012
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/529r7f/global)
has announced the addition of the "Global
Dermatology Drug Pipeline Capsule - 2012" report to their
offering.
Fore Pharma's latest report Global Dermatology Drug Pipeline Capsule -
2012' provides up-to-date information on key research and development
activities in the global dermatology drug market. It covers active
pipeline molecules under development in various stages of clinical
trials, preclinial research, and drug discovery for Acne, Alopecia,
Atopic Dermatitis, Malignant Melanoma, Psoriasis, and Rosacea.
This report helps executives track their competitor's pipeline
molecules. The information presented in this report can be used for
identifying partners, evaluating business opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
The report provides information on pipeline molecules by company,
mechanism of action, stage (phase 3 clinical trials, phase 2 clinical
trials, phase 1 clinical trials, preclinical research, and drug
discovery), and geography (North America, Europe, and Asia).
Key Features of the Report:
- Dermatology Drug Pipeline Insights
- Acne Drug Pipeline Insights
- Alopecia Drug Pipeline Insights
- Atopic Dermatitis Drug Pipeline Insights
- Malignant Melanoma Drug Pipeline Insights
- Psoriasis Drug Pipeline Insights
- Rosacea Drug Pipeline Insights
For more information visit http://www.researchandmarkets.com/research/529r7f/global

[ Back To Technology News's Homepage ]
|